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(Abstract) 29 
A novel lateral flow immunochromatographic device (LFD) was evaluated in several 30 
veterinary diagnostic laboratories. It was confirmed to be specific for Mycobacterium bovis 31 
and M. caprae cells. The performance of the novel LFD was assessed relative to the 32 
confirmatory tests routinely applied after culture (spoligotyping or qPCR) in each laboratory; 33 
liquid (MGIT or BacT/Alert) and/or solid (Stonebrink, Coletsos or Lowenstein-Jensen) 34 
cultures were tested. In comparison to spoligotyping of acid-fast positive MGIT cultures, 35 
percentage agreement between positive LFD and spoligotyping results was excellent in two 36 
UK laboratories (97.7-100%), but lower in the Spanish context (76%) where spoligotyping 37 
was applied to MGIT cultures previously confirmed to be positive for M. tuberculosis complex 38 
(MTBC) by qPCR. Certain spoligotypes of M. bovis and M. caprae were not detected by the 39 
LFD in Spanish MGIT cultures. Compared to qPCR confirmation, the percentage agreement 40 
between positive LFD and qPCR results was 42.3% and 50% for BacT/Alert and MGIT liquid 41 
cultures, respectively, and for solid cultures ranged from 11.1-89.2%, depending on solid 42 
medium employed (Coletsos 11.1%, Lowenstein-Jensen 55.6%, Stonebrinks 89.2%). 43 
Correlation between the novel LFD and BD MGIT TBc ID test results was excellent when 44 
190 MGIT cultures were tested (r = 0.9791; P<0.0001), with the added benefit that M. bovis 45 
was differentiated from another MTBC species in one MGIT culture by the novel LFD. This 46 
multi-laboratory evaluation has demonstrated the novel LFD’s potential utility as a rapid test 47 
to confirm isolation of M. bovis and M. caprae from veterinary specimens following culture.  48 
 49 
Keywords: Mycobacterium bovis, Mycobacterium caprae, lateral flow 50 
immunochromatographic assay, detection specificity, detection sensitivity, veterinary 51 
diagnostics 52 
 53 
 54 
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Bovine tuberculosis (bTB), caused primarily by Mycobacterium bovis, is endemic in 56 
many countries and constitutes a significant economic burden to the agricultural industries 57 
(1,2,3). Eradication of bTB is currently one of the biggest challenges facing the cattle 58 
industry worldwide and despite intensive eradication efforts over decades, bTB continues to 59 
be a problem with global perspective (4,5).  Amongst the plethora of factors identified as 60 
constraints to eradication are the limitations of existing diagnostic tests (6). Diagnosis of bTB 61 
is time consuming, and is compounded in some cases by the presence of non-tuberculosis 62 
mycobacteria (NTM) which represent a large and diverse population of mycobacteria which 63 
may interfere with diagnosis (7). In addition, although M. bovis is the main aetiological agent 64 
that causes tuberculosis in domesticated cattle and other wildlife and domesticated species, 65 
a very closely related species, Mycobacterium caprae, also causes a significant proportion of 66 
bTB cases in some European countries (8). Differentiation of NTM from organisms that 67 
cause bTB is currently only possible by nucleic acid amplification methods, such as PCR 68 
and spoligotyping, which are specific but are technically challenging and require 69 
sophisticated instrumentation making them expensive. More rapid, specific and sensitive 70 
detection and/or confirmatory methods for M. bovis that could potentially replace the 71 
currently used non-specific ZN stain and the expensive molecular based techniques are 72 
urgently required to expedite accurate diagnosis and reduce cost. 73 
 Mycobacterial culture is still regarded as the ‘gold standard’ technique for diagnosis 74 
of bTB (9), despite the fact that it is slow and cultures are sometimes subject to overgrowth 75 
by contaminants. Culture and identification techniques for M. bovis and M. caprae from 76 
veterinary specimens are not globally standardised, so consequently  a  range of both liquid 77 
and solid culture media are employed in veterinary diagnostic laboratories worldwide. The 78 
time taken to isolate these species by culture can be up to 12-14 weeks, and subsequent 79 
tests needed to confirm and speciate an isolate (Ziehl-Neelsen (ZN) staining and 80 
microscopy, PCR or qPCR, GenoType MTBC test, or spoligotyping) require additional time, 81 
cost and staff training and effort.  A rapid test to confirm isolation of M. bovis, rather than 82 
other members of the M. tuberculosis complex (MTBC) or an NTM in suspect positive liquid 83 
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or solid cultures is currently lacking. A novel rapid lateral flow, immunochromatographic 84 
(LFD) test to detect M. bovis, recently developed at Queen’s University Belfast (10), may 85 
represent such a confirmatory test.  86 
 Lateral flow, immunochromatographic tests are an inexpensive, quick and simple-to-87 
use format to visually detect a target of choice (11). Several such tests for detection of M. 88 
bovis, or MTBC species more generally, are available commercially. These detect either 89 
serum antibodies to M. bovis (BrockTB Stat-Pak® assay or DPP® CervidTB assay, both 90 
Chembio Diagnostic Systems, Inc., Medford, NY), or the MPT 64 antigen secreted by 91 
members of the MTBC, including M. bovis, in liquid culture (BD MGIT TBc Identification Test, 92 
Becton, Dickinson and Company, NJ; SD Bioline TB Ag MPT 64, Standard Diagnostics, Inc., 93 
Gyeonggi-do, Republic of Korea; Capilia TB-Neo kit, TAUNS Laboratories, Inc., Shizuoka, 94 
Japan). The commercially available MPT 64-based antigen detecting 95 
immunochromatographic tests have been shown to be highly reliable for rapid identification 96 
of MTBC organisms and as such are considered good alternatives to biochemical and 97 
molecular assays (12). However, none of these tests is able to distinguish M. bovis from 98 
other MTBC species, so the recently developed novel antibody-based LFD test is unique in 99 
this respect.  In the human clinical TB laboratory setting, the commercially available LFD 100 
tests (named above) are being used to differentiate MTBC species from NTM, in order to 101 
confirm isolation of MTBC from sputum cultures. According to the MGIT™ Procedure 102 
Manual (13), the number of M. tuberculosis cells present in a MGIT™ culture whenever it 103 
signals positive on the MGIT™ 960 instrument is 105-106 CFU/ml, which is higher than the 104 
limit of detection of the novel LFD (10). Therefore, in the veterinary TB laboratory setting, 105 
where the MGIT™ liquid culture system is also used, the novel LFD could potentially be 106 
used to quickly confirm isolation of M. bovis in liquid cultures of bovine lymph nodes (or other 107 
animal specimens) without the need for acid-fast staining and molecular techniques such as 108 
spoligotyping or real-time PCR.      109 
      The overall aim of this study was to determine if the novel LFD would be applicable in 110 
the veterinary laboratory setting to confirm isolation of M. bovis from diagnostic samples. 111 
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The objectives of the study were to: (i) evaluate the specificity of the novel LFD for M. bovis; 112 
(ii) assess the performance of the novel LFD relative to current culture confirmation 113 
approaches used in veterinary TB laboratories; (iii) evaluate the compatibility of the LFD with 114 
three different liquid mycobacterial culture media (BD MGIT, BioMerieux BacT/ALERT, and 115 
Trek Diagnostics VersaTREK Myco); and (iv) evaluate the performance of the novel LFD 116 
relative to the commercially available BD MGITTM TBc ID test for confirming presence of M. 117 
bovis in MGIT cultures in the veterinary diagnostic laboratory setting. Following initial 118 
evaluation of the LFD at Queen’s University Belfast (QUB) and in the statutory TB culture 119 
laboratory at Veterinary Sciences Division, Agri-Food and Biosciences Institute for Northern 120 
Ireland (AFBI), evaluation of the novel LFD was extended to four other veterinary TB 121 
laboratories.   122 
 123 
MATERIALS AND METHODS 124 
     Participating laboratories.  The following laboratories were involved in the study: TB 125 
Immunology Laboratory, Veterinary Sciences Division, Agri-Food and Biosciences Institute, 126 
Stormont, Belfast, Northern Ireland (AFBI); TB Laboratory, Animal and Plant Health Agency 127 
Starcross, Exeter, England (APHA); Laboratoire Départemental d'Analyse & de Recherche, 128 
Service Analyses Agriculture et Vétérinaire, Dordogne, France (DORDOGNE); Servicio de 129 
Micobacterias, Centro de Vigilancia Sanitaria Veterinaria, Madrid, Spain (VISAVET); 130 
Laboratorio Regional de Sanidad Animal, León, Spain (LRSA); and Laboratory of 131 
Immunology, Embrapa Gado de Corte, Campo Grande, MS, Brazil (EMBRAPA); The Animal 132 
TB Research Group, Stellenbosch University, South Africa (SUN). 133 
Description of novel lateral flow device (LFD).  A prototype LFD was developed 134 
by researchers at QUB in collaboration with Forsite Diagnostics Limited (now trading as 135 
Abingdon Health), York, England, as part of a United Kingdom Department of Environment, 136 
Food and Rural Affairs project (Defra SE3271).  It is an antibody-based antigen detection 137 
test, as defined by Office International des Epizooties (OIE) (14). The device comprises of a 138 
nitrocellulose membrane strip with a Test line (T) of an M. bovis-specific polyclonal IgG 139 
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antibody produced by QUB personnel and a Control line (C) of a commercially available anti-140 
mouse IgG antibody, and employs gold nanoparticles coated with an M. bovis-specific 141 
monoclonal IgG antibody, originally produced by AFBI personnel, as the labelled detector 142 
reagent. For Intellectual Property (IP) reasons no further details about the antibodies 143 
involved can be provided.  Additional detail on the development and optimisation of the M. 144 
bovis-specific LFD is available elsewhere (15). The prototype LFDs used in this study 145 
(approx. 1300 tests) were produced by Forsite Diagnostics Limited, and then distributed by 146 
QUB to participating laboratories by courier service, along with the required running buffer, 147 
blocking reagent and instructions for use. 148 
      LFD specificity checks.  Participating laboratories were requested to select cultures for 149 
LFD specificity testing, to reflect as broad a range of MTBC and NTM species as were 150 
available to them, and as representative a collection of strains for each species as possible. 151 
Prior specificity checks on the novel LFD had determined that it did not cross react with a 152 
range of Gram positive and Gram negative bacteria that may occur in cattle lymph nodes 153 
and human sputum (unpublished data).  The majority of strains tested were field isolates 154 
whose identification had been confirmed by a molecular method (spoligotyping, RD4/RD9 155 
analysis and/or 16S rRNA gene sequencing). The cultures tested had generally been freshly 156 
sub-cultured in/on various culture media (dictated by usual laboratory practice), including 157 
three different liquid media (MGIT from Becton Dickinson, BacT/ALERT from BioMerieux, 158 
versaTREK Myco from Thermofisher) and three different solid agar media (Coletsos, 159 
Lowenstein-Jensen and Stonebrink), before testing on the LFD.  However, older MGIT and 160 
solid mycobacterial cultures were tested in some of the laboratories.  When the LFD was 161 
used to test liquid cultures, 1 ml of culture was centrifuged at 14,000 rpm for 15 min and the 162 
pellet resuspended in 100 µl freshly prepared KPL Detector™ Block (KPL, Inc., 163 
Gaithersburg, MA, USA), before 80 µl was transferred to the sample well of the LFD.  When 164 
used to test solid cultures, a single colony was thoroughly emulsified in 100 µl KPL blocking 165 
solution and then 80 µl was transferred to the sample well of the LFD. In both instances, the 166 
LFD result was recorded after 15 min at room temperature, interpreted as follows: M. bovis 167 
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positive if two lines were visible; M. bovis negative if only a C line was visible; and ‘Invalid 168 
test’ result if only a T line was present, or neither T nor C lines were present.  In the latter 169 
case, if additional LFDs were available, the LFD test was repeated with a 10-fold dilution of 170 
the resuspended pellet of that particular culture to determine if that yielded a valid result. 171 
      Assessment of the performance of the novel LFD applied to liquid and solid 172 
cultures of veterinary specimens in comparison to current confirmation approaches.  173 
In order to assess the ability of the novel LFD to confirm isolation of M. bovis, each 174 
laboratory tested selected liquid and/or solid cultures, whichever were available, and 175 
provided LFD results along with results obtained using their currently applied confirmatory 176 
approach (ZN staining and spoligotyping, or qPCR) to QUB.  Variable numbers of cultures of 177 
tissues from different animals (cattle, badgers, wild boar, deer, goats) were tested in each 178 
laboratory.   179 
      At the statutory veterinary TB laboratory in Northern Ireland (AFBI) tissue specimens 180 
from skin test reactor cattle, or bovine lymph nodes detected at routine slaughter, are 181 
chemically decontaminated and cultured in MGIT liquid culture medium and on Lowenstein-182 
Jensen (LJ), Middlebrook 7H11 and/or Stonebrink slopes. Confirmation of isolation of M. 183 
bovis is carried out by spoligotyping of DNA from acid-fast positive MGIT cultures or from 184 
suspect colonies on solid media. In an initial assessment, 240 MGIT cultures were selected 185 
to be tested, comprising of 40 each of six different categories of MGIT culture and ZN 186 
outcome commonly encountered in this laboratory: (1) MGIT positive, ZN 3+; (2) MGIT 187 
positive, ZN 2+; (3) MGIT positive, ZN 1+; (4) MGIT positive, ZN ‘atypical’; (5) MGIT positive, 188 
ZN negative; (6) MGIT negative, ZN not done.  LFD testing did not commence until all 189 
samples for all categories became available, so these MGIT cultures were not tested in ‘real-190 
time’, i.e. as they indicated growth positive on the MGIT 960 machine or completed the 56 191 
day incubation period. Rather, they were removed from the MGIT 960 instrument, ZN 192 
stained to permit culture categorisation, and then kept in an incubator until all required 193 
cultures became available. The 240 MGIT cultures were blind coded before the QUB post-194 
doc tested each culture on the LFD.  Subsequently, an additional 105 MGIT cultures were 195 
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tested in ‘real-time’ by AFBI personnel as soon as possible after they indicated positive on 196 
the MGIT 960 instrument, or as they finished the 56 d incubation on the MGIT system. 197 
 The statutory veterinary TB laboratory in England (APHA Starcross) uses a similar 198 
confirmatory approach to AFBI; spoligotyping is used to confirm isolation of M. bovis in liquid 199 
cultures, but isolates on solid agar are reported on the basis of colony morphology with 200 
confirmation by spoligotyping at the herd breakdown level only. At APHA, 190 MGIT cultures 201 
were selected for LFD testing, categorised on the basis of solid and liquid culture outcomes 202 
and ZN result as follows: (A) solid and MGIT positive, ZN positive; (B1) solid negative, MGIT 203 
positive, ZN positive; (B2) solid negative, MGIT positive, ZN negative; and (C) solid and 204 
MGIT negative, ZN not done.     205 
 In contrast to AFBI and APHA TB test procedures, at the laboratories in Spain 206 
(VISAVET and LRSA), France (DORDOGNE) and Brazil (EMBRAPA), MGIT liquid culture, 207 
or BacT/ALERT and versaTREK Myco liquid culture, and solid culture on Coletsos, LJ (with 208 
pyruvate) or Stonebrink media are variously employed after decontamination of veterinary 209 
specimens, and real-time qPCR methods, which vary by country, are routinely used to 210 
confirm the isolation of MTBC in liquid culture; spoligotyping would only be carried out on 211 
some cultures.  In the Brazilian laboratory, two qPCR methods targeting TbD1 (16) and 212 
Rv2807 (17) are employed. In the French laboratory, a qPCR targeting IS6110 is employed 213 
for diagnosis currently (18). The Spanish laboratories use an unpublished qPCR method 214 
targeting the region between Rv0953c-Rv0954 for MGIT liquid cultures (Elena Alonso, 215 
LRSA, personal communication) and spoligotyping for isolates on solid LJ medium.  216 
      Comparison of the performance of novel LFD and commercially available BD 217 
MGITTM TBc ID test applied to MGIT™ cultures. Personnel at the APHA laboratory tested 218 
the 190 MGIT cultures of veterinary specimens mentioned above by the BD MGIT™ TBc ID 219 
test (Becton Dickinson, Sparks, Maryland, USA) in parallel with the novel LFD test.  This 220 
permitted direct comparison of the performance of the two LFDs.  221 
      Statistical analysis of results.  For each laboratory the percentage of spoligotyping- or 222 
qPCR- confirmed cultures that tested positive by the LFD was calculated for liquid or solid 223 
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cultures, as appropriate. Correlation between numbers of samples positive by LFD and by 224 
qPCR at DORDOGNE, VISAVET/LRSA and EMBRAPA was assessed by Spearman’s rank 225 
correlation coefficient.  Cross-tabulation of the novel LFD and BD TBc ID test results for the 226 
190 MGIT cultures tested at APHA permitted determination of a Kappa statistic, as a 227 
measure of the agreement between the two tests, which was interpreted according to Landis 228 
and Koch (22).  Fisher’s Exact Test was also performed on the results for each LFD and 229 
confirmed MGIT culture results (i.e. after spoligotyping of acid-fast positive liquid cultures) to 230 
permit estimation of detection sensitivity and specificity of each LFD applied to MGIT 231 
cultures of veterinary specimens. Statistical tests were performed using GraphPad Instat® 232 
3.10 (GraphPad Software Inc., La Jolla, CA, USA).   233 
 234 
RESULTS 235 
      Specificity of the novel LFD.  Pure cultures of MTBC species (all except M. canetti) 236 
plus a broad range of NTM were tested on the novel LFD.  Some species were available as 237 
liquid cultures and some as solid cultures within the various participating laboratories.  In the 238 
EMBRAPA laboratory only solid cultures were available, some of which were freshly 239 
prepared and others were described as ‘old and difficult to emulsify’. LFD test results for all 240 
pure liquid and solid cultures tested are summarised in Table 1 and Table 2, respectively. In 241 
total 85 different strains of M. bovis, 41 of M. tuberculosis (all of human origin) and 1-4 242 
isolates of 29 different NTM (including both type and field strains) were tested across all of 243 
the laboratories. The M. bovis isolates tested as part of the specificity evaluation were 244 
predominantly from cattle, but also included isolates from goats and wild boar (VISAVET and 245 
LRSA), lions, mongooses, baboons, civet, hyena and buffalo (SUN), and badgers 246 
(DORDOGNE). The M. bovis strains tested represent a broad range of different spoligotypes 247 
(some information is provided in footnotes of Tables 1 and 2). 248 
 Results in Tables 1 and 2 indicate that the novel LFD gave a positive result with M. 249 
bovis, M. caprae and M. bovis BCG, and, also with the two strains of M. pinnipedii tested. 250 
Overall, 41 (95.3%) of the 43 M. bovis strains tested as liquid cultures yielded a positive LFD 251 
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result. In contrast, when solid cultures were tested only 60 (75%) of the 80 M. bovis strains 252 
tested yielded a positive result (Table 2).  Some false negative or ‘invalid’ LFD results for 253 
confirmed M. bovis strains (including M. bovis BCG) and M. caprae strains were 254 
encountered, particularly with colonies from Coletsos (9/14 strains in DORDOGNE tested 255 
LFD negative), LJ (4/9 and 5/10 strains in DORDOGNE and VISAVET, respectively, tested 256 
LFD negative) and Stonebrinks slopes (8/60 strains at EMBRAPA tested LFD negative) 257 
(Table 2).  258 
 Performance of novel LFD applied to liquid and solid cultures compared to 259 
confirmation by spoligotyping.  At AFBI, MGIT cultures exhibiting growth are ZN stained 260 
and only spoligotyped if acid-fast cells are observed to be present.  When 160 MGIT cultures 261 
categorised on the basis of growth and ZN result were tested at AFBI, the LFD indicated the 262 
presence of M. bovis in 118 (98.3 %) of 120 ZN positive MGIT cultures (scored 1+, 2+ or 3+; 263 
categories 1-3), in 20 (50 %) of 40 MGIT cultures recorded as having an ‘atypical’ ZN result 264 
(category 4), and in 4 (10%) of 40 ZN negative MGIT cultures (category 5). ZN negative 265 
MGIT positive cultures are not routinely spoligotyped at AFBI, so the potential presence of 266 
an M. bovis spoligotype in the ZN negative MGIT cultures that tested LFD positive cannot be 267 
excluded. All 40 growth negative MGIT cultures (category 6) tested negative by the LFD.  268 
When positive LFD results were compared with the spoligotyping outcome for the MGIT 269 
cultures, there was 100% agreement between an LFD positive culture and the presence of 270 
an M. bovis spoligotype (Table 3).  When AFBI personnel subsequently tested 105 MGIT 271 
cultures in ‘real-time’, i.e. as soon as possible after they had flagged positive on the MGIT 272 
960 instrument, there was still 100% agreement between an LFD positive culture and the 273 
presence of an M. bovis spoligotype, but, as was the case for the categorised MGIT cultures 274 
(detailed above), an additional two ZN negative cultures tested LFD positive.   275 
 At APHA, when 190 routine MGIT cultures of bovine lymph tissue samples 276 
categorised on the basis of growth on the MGIT system and ZN result were tested, 90 of the 277 
103 MGIT cultures in categories A and B1 were confirmed to contain MTBC by 278 
spoligotyping, and 89 contained M. bovis. The novel LFD indicated the presence of M. bovis 279 
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in 88 (98.9%) of these 89 M. bovis positive MGIT cultures (Table 3).  The other two LFD 280 
negative but MTBC positive MGIT cultures did contain M. bovis in one case (so a false 281 
negative LFD result) but another MTBC species in the other case (so a true negative LFD 282 
result).  None of 87 ZN negative MGIT cultures (categories B2 and C) tested LFD positive.  283 
The Spanish laboratories (VISAVET and LRSA) tested MGIT cultures of tissues from 284 
four different animal species (cattle, goats, deer and wild boar), in contrast to most other 285 
participating laboratories, where cattle tissues were principally cultured. For the purposes of 286 
this study, spoligotyping was carried out on the qPCR positive MGIT cultures to confirm if M. 287 
bovis or M. caprae were present. Overall, of the 50 VISAVET/LRSA MGIT cultures where 288 
either M. bovis or M. caprae were identified to be present by spoligotyping, 39 MGIT cultures 289 
tested LFD positive (76% agreement, Table 3).  When the M. bovis and M. caprae 290 
spoligotypes present in the LFD negative MGIT cultures were considered, it became 291 
apparent that MGIT cultures containing certain spoligotypes of M. bovis (SB0121, SB0134, 292 
SB0152, SB0295 and SB0339) and M. caprae (SB0157, SB0415 and SB0416), isolated 293 
from cattle and goat specimens, had not been detected by the novel LFD (Table 4).  294 
     Performance of novel LFD applied to liquid and solid cultures compared to qPCR 295 
confirmation of MTBC isolation. Real-time qPCR, rather than ZN staining and 296 
spoligotyping of acid-fast cultures, was routinely being used in the non-UK laboratories to 297 
confirm the isolation of MTBC from veterinary specimens after liquid and/or solid culture, 298 
although different qPCR methods were being used in the three laboratories.  Results of 299 
liquid culture testing at VISAVET/LRSA and DORDOGNE are shown in Figure 1, and for 300 
solid culture testing at EMBRAPA in Figure 2. In these figures results are presented for LFD 301 
and qPCR as the number of cultures LFD positive when the CT value of the MGIT culture, or 302 
the emulsified suspect colony, was ‘x’, and no. of cultures yielding a CT value of ‘x’ by qPCR, 303 
respectively.  Correlation between numbers of cultures testing positive by the two tests was 304 
assessed using Spearman’s rank correlation coefficient (GraphPad Instat® 3.10). For 305 
VISAVET/LRSA results (Figure 1A) there was found to be significant correlation between 306 
numbers of cultures testing LFD and qPCR positive for MGITTM cultures yielding CT values 307 
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from 17-26 (Spearman’s r = 0.9271; P=0.0003), however for cultures yielding CT values >26 308 
there was no significant correlation (Spearman’s r = 0.1164; P=0.7185) between the two 309 
tests. Similarly, for the DORDOGNE results (Figure 1B) there was found to be significant 310 
correlation between numbers testing LFD and IS6110 qPCR positive for BacT/ALERT 311 
cultures yielding CT values from 14-27 (Spearman’s r = 0.830; P=0.0003), however for 312 
cultures giving CT values >27 there was no significant correlation (Spearman’s r = 0.1164; 313 
P=0.7185) between the two tests.  These results indicate that the limit of detection of the 314 
qPCR methods is lower than that of the LFD, meaning that qPCR applied to liquid cultures 315 
will detect higher numbers of MTBC positive cultures than testing by the LFD, however, as 316 
the qPCR methods employed are neither M. bovis nor M. caprae specific the presence of 317 
other MTBC species in some of these samples cannot be ruled out.  318 
 VISAVET/LRSA and DORDOGNE liquid culture test results were also analysed in 319 
terms of percentage agreement between positive LFD and qPCR results (Table 3).  The 320 
percentage agreement between positive LFD and qPCR results at VISAVET/LRSA was 50 321 
% (39 of 78 cultures); which was lower than agreement between spoligotyping and LFD 322 
results (76 %, 38 of 50 confirmed M. bovis or M. caprae positive cultures). When CT values 323 
of the 50 cultures confirmed by spoligotyping were considered, all except three had CT 324 
values  30, which is consistent with the trend illustrated in Figure 1A. DORDOGNE was the 325 
only participating laboratory using the BacT/Alert liquid culture system rather than the MGIT 326 
culture system, and it was the only laboratory to report ‘invalid’ LFD results (i.e. no C line in 327 
the presence or absence of a T line) when testing liquid cultures.  As a consequence of this, 328 
percentage agreement between LFD and qPCR positive results for liquid cultures of 329 
veterinary specimens tested at DORDOGNE was lowest at 42.3% (Table 3).  330 
 EMBRAPA results exclusively represented testing of emulsified colonies from solid 331 
cultures of bovine specimens by two different confirmatory qPCRs and LFD (Figure 2). 332 
There was significant correlation between numbers of cultures testing LFD positive and 333 
TbD1 qPCR positive (Spearman’s r = 0.973, P=0.0001).  For qPCR targeting TbD1, CT 334 
values of emulsified colonies from 60 agar slants ranged from 12.5–25.0. Of these, 52 335 
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(91.2%) of 57 emulsified colonies with CT values ranging from 12.5–22.5 tested LFD 336 
positive, and three with CT values >23 tested LFD negative (Figure 2A). Similar results were 337 
observed with the second qPCR targeting Rv2807 applied to emulsified colonies. There was 338 
significant correlation between numbers of cultures testing LFD positive and Rv2807 qPCR 339 
positive (Spearman’s r = 0.967, P=0.0001).  For Rv2807 qPCR, CT values of emulsified 340 
colonies from 60 agar slants ranged from 12.64–25.94. Of these, 52 (88.1%) of 59 341 
emulsified colonies with CT values ranging from 12.64–23.0 tested LFD positive, and one 342 
with CT value of 25.94 tested LFD negative (Figure 2B).  Both fresh and old confirmed M. 343 
bovis cultures on Stonebrink slopes were tested by EMBRAPA; 89.2 and 82.6% of fresh and 344 
old solid cultures, respectively, were confirmed to be M. bovis by the LFD (Table 5). No 345 
‘invalid’ LFD results were reported by EMBRAPA (just some difficulties in emulsifying 346 
colonies in KPL buffer on occasion); in contrast to the DORDOGNE laboratory where 8 of 9 347 
Coletsos cultures and 4 of 9 LJ cultures yielded an ‘invalid’ result (Table 5). The latter 348 
resulted in only 11.1 and 55.6% of solid cultures being confirmed as M. bovis by the LFD in 349 
the French context (Table 5). 350 
     Correlation between the results of the novel LFD and the commercially available 351 
BD MGITTM TBc ID test.  A total of 190 MGITTM cultures of bovine specimens were tested in 352 
parallel by the novel LFD and BD MGIT™ TBc ID tests at APHA. Correlation between results 353 
was assessed using Spearman’s rank correlation coefficient, which indicated significant 354 
correlation between results obtained with the two LFDs (r = 0.9791; P<0.0001).  LFD results 355 
are presented as separate 2x2 contingency tables relative to confirmed culture result (on the 356 
basis of spoligotyping) for the two LFDs in Table 6. There were two MGIT cultures with 357 
discordant results with the two LFD tests – one culture was MTBC positive but confirmed M. 358 
bovis negative by spoligotyping, so correctly tested negative by the novel LFD but positive 359 
by the BD MGITTM TBc ID test, and the other culture was confirmed M. bovis positive by 360 
spoligotyping and tested falsely negative by the novel LFD but correctly positive by the BD 361 
MGITTM TBc ID test (Table 6).  There were an additional two MGIT™ cultures that yielded 362 
negative results by both LFD tests when different results were expected; in one case both 363 
14 
 
tests should have yielded positive results because M. bovis was confirmed to be present by 364 
spoligotyping, and in the other case the BD MGITTM TBc ID test should have yielded a 365 
positive result because an MTBC species other than M. bovis was indicated by 366 
spoligotyping.  When the commercial and novel lateral flow tests were used to confirm the 367 
presence of M. bovis in MGIT cultures of veterinary specimens, the detection specificity and 368 
sensitivity of both LFD tests were comparable - 1.000 and 0.978, respectively, for the novel 369 
LFD, and 0.990 and 0.989, respectively, for the BD MGIT TBc ID test.  370 
 371 
DISCUSSION 372 
Evaluation of the novel LFD test was carried out in multiple veterinary diagnostic laboratories 373 
located in different geographic regions, processing specimens from a range of animal 374 
species, and using differing bTB diagnostic algorithms,in the hope that the results of the 375 
study would provide a wide-ranging assessment of its potential utility as a quick and easy 376 
end point test to confirm isolation of M. bovis from animal specimens in the veterinary 377 
diagnostic context. Veterinary diagnostic laboratories in different countries adopt differing 378 
approaches for confirming isolation of MTBC after culture of animal specimens. The bTB 379 
diagnostic algorithm adopted is dependent mostly on the current prevalence of tuberculosis 380 
in the country, which dictates whether testing is being carried out for disease surveillance, 381 
control or eradication purposes.  For example, bTB is endemic in Northern Ireland (herd 382 
prevalence 7.15% and animal incidence 0.66%, (20)) and England and Wales (herd 383 
prevalence ~7.8%, (21,22)), so in the UK context confirmation of isolation of M. bovis from 384 
bovine specimens is achieved by colony morphology on solid agar or ZN staining and 385 
spoligotyping of DNA extracted from acid-fast positive liquid cultures. Spoligotyping 386 
facilitates epidemiological studies and provides transmission data required for control and 387 
eradication in the UK context.  In contrast, herd prevalences of bTB in cattle in France 388 
(~0.05%, Jean-Louis Moyen, DORDOGNE, personal communication) and Spain (2.81%, 389 
(23)) are lower, but there is a recognised threat of reintroduction of the disease due to 390 
wildlife ‘spill-back’ (24,25). In these contexts a more sensitive qPCR approach to confirming 391 
15 
 
the isolation of M. bovis (or M. caprae since this species is also encountered) in liquid and 392 
solid cultures has been adopted; ZN staining is not routinely employed and all isolates would 393 
not necessarily be spoligotyped. Similarly, in Brazil, a recent epidemiological survey 394 
indicated the prevalence of TB in infected cattle ranged from 0.035 to 1.3% in the 13 States 395 
surveyed (26), so qPCR confirmation methods are adopted.    396 
 A wide range of NTM and MTBC strains from both solid and liquid cultures was 397 
tested to evaluate the specificity of the novel LFD. The results (Tables 1 and 2) confirmed 398 
that the LFD was specific for M. bovis in the broadest sense, since M. bovis, M. caprae and 399 
M. bovis BCG all gave rise to both positive T and C lines on the device.  Detection of M. 400 
caprae by the novel LFD would be viewed as beneficial, since this MTBC species is the main 401 
aetiological agent of tuberculosis in goats, but also in cattle in certain countries. For 402 
example, in Spain around 7% of bTB cases in cattle are due to M. caprae (8), and in some 403 
central/eastern European countries TB infection in cattle is only due to M. caprae (27).  404 
However, M. caprae strains with different RD4 deletions have been isolated in parts of 405 
Europe (ML Boschiroli, personal communication; 28); which may explain some of the 406 
negative LFD results obtained for colonies of 5 of 10 M. caprae strains from solid 407 
LJ/pyruvate medium and 5 of 8 confirmed M. caprae positive MGIT liquid cultures tested by 408 
VISAVET/LRSA (Table 2).  Alternatively, certain spoligotypes may not be detectable by the 409 
LFD.  In phylogenetic terms, amongst the MTBC species, M. pinnipedii and M. microti are 410 
closest to M. bovis, M. caprae and M. bovis BCG (27). A positive result on the novel LFD 411 
was obtained with the single liquid and single solid cultures of M. pinnipedii tested, however, 412 
this Mycobacterium sp. is primarily isolated from seals and is rarely encountered in cattle or 413 
food animals (29). M. microti can sometimes be encountered in cats, badgers or wild boars 414 
in the UK and French contexts, but rarely in food animals (30) so it is advantageous that the 415 
two liquid cultures and one solid culture of M. microti tested negative with the novel LFD.  416 
 Once the detection specificity of the LFD had been demonstrated, the diagnostic 417 
performance of the LFD was assessed by comparing LFD results with those of current 418 
nucleic acid-based confirmatory tests (spoligotyping and qPCR) employed in the various 419 
16 
 
laboratories.  Few issues were encountered by personnel using the LFD for the first time, or 420 
in interpretation of LFD results. Some false negative, or invalid (no C-line), LFD results 421 
occurred, mainly when testing BacT/ALERT liquid cultures or emulsified confirmed M. bovis 422 
colonies from Coletsos and LJ solid media in the DORDOGNE laboratory  (Tables 3 and 5). 423 
When testing colonies it may be that cells were not adequately disaggregated and so 424 
clumped cells were too big to pass along the LFD to reach the T and C lines to generate a 425 
positive result.  An alternative explanation could be that too many cells passing along the 426 
LFD may have quenched or prevented binding of cell/particle complexes at the T and/or C 427 
lines leading to false negative or invalid test outcomes (Dene Baldwin, Abingdon Health, 428 
personal communication). In the DORDOGNE laboratory some BacT/ALERT liquid cultures 429 
that initially gave a negative or invalid LFD result when retested after 10-fold dilution yielded 430 
a valid result (i.e. presence of a C-line) or a clear positive result; which appeared to confirm 431 
two things - that too much biomass was the cause of false negative results, and that higher 432 
numbers of M. bovis were present in positive BacT/ALERT cultures than in positive MGIT 433 
cultures.  EMBRAPA personnel mentioned difficulties in emulsifying some of the older M. 434 
bovis colonies, however, they did not report any ‘invalid’ LFD results. It is clear that some 435 
more optimisation of the LFD test procedure in relation to its application to confirm the 436 
identity of suspect colonies from solid culture media and in liquid culture systems other than 437 
BD MGIT 960 system would be needed. This would include optimising the density of a 438 
colony suspension relative to the universally used McFarland scale before application to the 439 
LFD.   440 
 The results of this study clearly show that the novel LFD performed better relative to 441 
culture confirmation by spoligotyping than culture confirmation by qPCR. In the UK 442 
laboratories (AFBI and APHA) percentage agreement between spoligotyping and LFD 443 
results for liquid MGIT cultures was 97.7-100% (Table 3). Therefore, the LFD could 444 
potentially be used instead of ZN and spoligotyping for routine and rapid confirmation of M. 445 
bovis isolation in cultures of veterinary specimens once growth is indicated by the MGIT 960 446 
culture system in the UK context. However, since spoligotyping is also carried out to provide 447 
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valuable epidemiological information (31-35), it is probably unlikely that the LFD test would 448 
replace spoligotyping completely in these laboratories. Some extra M. bovis positive MGIT 449 
cultures were indicated by LFD testing compared to ZN staining, so if the LFD were adopted 450 
in the UK context this could potentially more efficiently direct spoligotyping efforts than ZN 451 
staining of MGIT cultures currently does. In the Spanish context percentage agreement 452 
between the spoligotyping and LFD results was lower at 76%. Results suggest that isolates 453 
of certain spoligotypes of both M. bovis (SB0121, SB0134, SB0152, SB0295 and SB0339) 454 
and M. caprae (SB0157, SB0415 and SB0416) were not being detected by the LFD (Table 455 
4). However, it should be noted that VISAVET/LRSA did not apply ZN staining prior to 456 
spoligotyping of qPCR positive MGIT cultures; which may also have contributed to the lower 457 
percentage agreement figure. 458 
 Various qPCR methods are routinely employed to confirm the isolation of MTBC 459 
species in liquid or solid cultures from veterinary diagnostic specimens in the non-UK 460 
laboratories (DORDOGNE, VISAVET/LRSA and EMBRAPA).  It is evident from the results of 461 
this study that the novel LFD is less sensitive than qPCR.  This is not a surprising finding 462 
given that the limit of detection of the LFD is 104-105 M. bovis cells/ml of sample (10) and the 463 
limit of detection of qPCR methods for MTBC is generally much lower than this (18); for 464 
example, the limit of detection of the French IS6110 qPCR is 3 genomic units (Jean-Louis 465 
Moyen, DORDOGNE, personal communication).  Results presented in Figures 1 and 2 466 
suggest that the limit of detection of the novel LFD is whatever number of M. bovis cells a CT 467 
value in the mid to high 20s corresponds to. This number may differ depending on the qPCR 468 
method employed, but is likely to be a reasonably high number of M. bovis, which would 469 
concur with the limit of detection of the LFD previously determined using spiked faeces and 470 
dilutions of M. bovis cultures at QUB (10).  Unfortunately, information on what number of M. 471 
bovis cells equates to a CT value in the mid-20s was not obtainable from any of the three 472 
laboratories concerned; in these laboratories the qPCR methods were being used 473 
qualitatively and not for quantification. 474 
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 During this study, liquid and/or solid cultures of veterinary specimens from a variety 475 
of animal species were tested in the participating laboratories. In the AFBI, APHA and 476 
DORDOGNE laboratories, liquid cultures of principally cattle and some badger specimens 477 
were tested by the novel LFD.  In the EMBRAPA laboratory exclusively cattle cultures 478 
isolated on solid media were tested.  However, in the VISAVET and LRSA laboratories MGIT 479 
liquid cultures tested were of cattle, goats, deer and wild boar specimens.  The LFD seemed 480 
to perform less well on cattle and goat liquid cultures in the Spanish context; several M. 481 
bovis and M. caprae spoligotypes were seemingly not detectable by the LFD (Table 4).  In 482 
Spain around 7% of bTB cases in cattle are due to M. caprae (8), and TB cases in goats in 483 
Spain can be caused by either M. bovis or M. caprae (36). It has previously been reported 484 
that 62 different spoligotypes were identified amongst MTBC isolates collected from wild 485 
ungulates and livestock in Spain (37). Given the diversity of MTBC spoligotypes that are 486 
encountered in the Spanish veterinary diagnostic context, perhaps it is the case that certain 487 
spoligotypes of M. bovis and M. caprae occurring in Spanish animals are not detectable by 488 
the combination of antibodies (originally generated using M. bovis AF2122/97, a UK cattle 489 
strain with spoligotype SB0140) employed on the LFD. This may also explain the negative 490 
LFD results obtained for 5 (50%) of 10 pure cultures of M. caprae tested from solid medium 491 
(Table 2) and 12 (24%) of 50 MGIT cultures of Spanish veterinary specimens with low qPCR 492 
CT values that were confirmed to contain either M. bovis or M. caprae by spoligotyping 493 
(Table 4).     494 
 Commercially available antibody-based LFD tests, which target MPT64 or MPT70 495 
secreted antigens, not whole cells, and detect MTBC species more generally have been . 496 
The BD MGIT TBc ID immunochromatographic assay has been comprehensively evaluated 497 
in human clinical TB laboratories to speciate mycobacterial isolates to the level of MTBC or 498 
NTM  (38-42). The BD LFD and other similar commercially available MPT64-based LFD 499 
tests perform very well in the clinical TB context and have been found to be good 500 
alternatives to biochemical and molecular assays for identification to the level of MTBC 501 
species in cultures of respiratory specimens (12). To our knowledge, there have been no 502 
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previous reports of the BD MGIT TBc ID test being evaluated for use in the veterinary TB 503 
diagnostic setting. In this latter context, M. bovis and M. caprae (in certain geographic 504 
regions), rather than M. tuberculosis, are the MTBC species most commonly isolated, and 505 
confirmation of isolation of M. bovis or M. caprae is achieved by spoligotyping, or of MTBC 506 
isolation more broadly by a specific qPCR.  A quicker and cheaper confirmatory test, that is 507 
able to confirm isolation of M. bovis or M. caprae but doesn’t require expensive equipment, 508 
or a lot of staff training or time, should be an attractive proposition for a veterinary TB 509 
laboratory.  During this study the performance of the novel LFD was found to be comparable 510 
to that of the BD MGIT TBc ID test for confirming isolation of M. bovis in MGIT liquid cultures 511 
of veterinary specimens at APHA in terms of detection sensitivity and specificity. However, 512 
the extra differentiation between M. bovis and other species of the MTBC possible using the 513 
novel LFD would potentially be a more attractive proposition for the APHA laboratory than 514 
simply confirming isolation of MTBC.   515 
 In conclusion, evaluation of the novel LFD in multiple veterinary TB laboratories in 516 
various parts of the world has demonstrated that the novel LFD could find application in the 517 
veterinary diagnostic setting to confirm isolation of M. bovis or M. caprae (depending on 518 
geographical context) in liquid cultures (assuming sufficient cell numbers are present), and 519 
also to test suspect colonies from solid culture media. The LFD was shown to have excellent 520 
specificity for this purpose, and its unique ability to differentiate M. bovis and M. caprae from 521 
other MTBC and NTM was clearly demonstrated; in contrast to other commercially available 522 
antibody-based LFD tests. The novel LFD possessed sufficient sensitivity to confirm the 523 
isolation of M. bovis or M. caprae in liquid cultures once they indicated positive on the MGIT 524 
960 or BACT/Alert culture systems, with a few exceptions.    525 
 526 
Acknowledgments 527 
This research was financed by the European Regional Development Fund under the 528 
European Sustainable Competitiveness Programme for Northern Ireland 2007-2013 via a 529 
Proof-of-Concept Grant from Invest Northern Ireland. APHA staff were funded under Defra 530 
20 
 
project SB4300.   We thank all the personnel in the various laboratories who contributed in 531 
any way to generation of the results presented.  532 
 The study was conceived by I.G. and L.S.; LFD evaluation and data collection were 533 
conducted by L.S., L.McC., J.McN., J-L.M., L.De J., E.A., R.M., A.McG., S.P. and F.A.; data 534 
analysis and interpretation were conducted by I.G. in consultation with L.McC., J-L.M., 535 
L.deJ., B.R., E.A., S.P. and F.A; and I.G. and L.S. wrote the first draft of the manuscript. All 536 
authors contributed to the final manuscript. 537 
 538 
REFERENCES 539 
1. Reynolds D. 2006. A review of tuberculosis science and policy in Great Britain. Vet. 540 
Microbiol. 112: 119-126  541 
2. Butler A, Lobley M, Winter M. 2010.  Economic Impact Assessment of Bovine. 542 
Tuberculosis in the South West of England CRPR Research Report No. 30. 543 
www.centres.ex.ac.uk/crpr/publications/3. Amanfu W. 2006. The situation of tuberculosis 544 
and tuberculosis control in animals of economic interest. Tuberculosis 86: 330-335 545 
4. Reviriego Gordejo FJ, Vermeersch JP. 2006. Towards eradication of bovine 546 
tuberculosis in the European Union. Vet Microbiol 112:101–109. 547 
5. More SJ, Radunz B, Glanville RJ. 2015. Lessons learned during the successful 548 
eradication of bovine tuberculosis from Australia. Vet Rec 177:224-232. 549 
6. Schiller I, Oesch B, Vordermeier HM, Palmer MV, Harris BN, Orloski KA, Buddle, 550 
BM, Thacker TC, Lyashchenko KP, Waters WR. (2010), Bovine Tuberculosis: A Review of 551 
Current and Emerging Diagnostic Techniques in View of their Relevance for Disease Control 552 
and Eradication. Transboundary and Emerging Diseases, 57: 205–220.  553 
7. Biet F, Boschiroli ML.  2014. Non-tuberculous mycobacterial infections of veterinary 554 
relevance. Research in Veterinary Science, 97 (Suppl.) (2014), pp. S69-S77 555 
8. Rodríguez S, Bezos J, Romero B, de Juan L, Álvarez J, Castellanos E, Moya N, 556 
Lozano F, Javed MT, Sáez-Llorente JL, Liébana E, Mateos A, Domínguez L, Aranaz A., 557 
21 
 
and The Spanish Network on Surveillance and Monitoring of Animal Tuberculosis. 558 
2011. Mycobacterium caprae infection in livestock and wildlife, Spain. Emerg. Infect. Dis. 17: 559 
532-535. 560 
9.  Office International des Epizooties. 2009.  Chapter 2.4.7. – Bovine Tuberculosis.  In 561 
OIE Terrestrial Manual 2009.  562 
https://web.oie.int/eng/normes/MMANUAL/2008/pdf/2.04.07_BOVINE_TB.pdf (last 563 
accessed 10 March 2017). 564 
10. Stewart LD, Tort N, Meakin P, Argudo JM, Nzuma R, Reid N, Delahay RJ, Ashford 565 
R, Montgomery WI, Grant IR. 2017. Development of a novel immunochromatographic 566 
lateral flow assay specific for Mycobacterium bovis cells and its application in combination 567 
with immunomagnetic separation to test badger faeces. BMC Veterinary Research 568 
13:131. DOI: 10.1186/s12917-017-1048-x  569 
11. Eltzov E, Guttel S, Adarina LYK, Sinawang PD, Ionescu RE, Marks RS. 2015. Lateral 570 
flow immunoassays – from paper strip to smartphone technology.  Electroanalysis 27:1-571 
16. 572 
12. Yin X, Zheng L, Lin L, Hu Y, Zheng F, Hu Y, Wang Q. 2013.  Commercial MPT64-573 
based tests for rapid identification of Mycobacterium tuberculosis complex: a meta-574 
analysis. J Infect 67:369-377.   575 
13. Siddiqi SH, Rüsch-Gerdes S. 2006. MGIT™ Procedure Manual.  Foundation for 576 
Innovative New Diagnostics, Geneva, Switzerland. http://www.finddx.org/wp-577 
content/uploads/2016/02/mgit_manual_nov2006.pdf. 578 
14. Office International des Epizooties. 2014. Validation Guideline 3.6.2.  Development 579 
and optimisation of antigen detection assays. In OIE Validation Guidelines 2014, 580 
http://www.oie.int/fileadmin/Home/eng/Health_standards/tahm/GUIDELINE_3.6.2_ANTIG581 
EN_DETECT.pdf . 582 
15. Department of Environment, Food and Rural Affairs. 2014. EVID4 Final Report on 583 
Defra Project SE3271: Development and field validation of a rapid immunomagnetic 584 
22 
 
separation-lateral flow (IMS-LF) test for detecting Mycobacterium bovis infection in 585 
badgers and/or badger setts. 586 
http://randd.defra.gov.uk/Document.aspx?Document=13141_SE3271.pdf. 587 
16. Araújo CP, Osório ALAR, Jorge KSG, Ramos CAN, Filho AFS, Vidal CES, Roxo E, 588 
Nishibe C, Almeida NF, Fonseca Júnior AAJr, Silva MR, Barbosa Neto JD, 589 
Cerqueira VD, Zumárraga MJ, Araújo FR. 2014. Detection of Mycobacterium bovis in 590 
bovine and bubaline tissues using nested-PCR for TbD1. PLoS ONE 9: e91023.  591 
17. Araújo CP, Osório ALAR, Jorge KSG, Ramos CAN, Filho AFS, Vidal CE, Vargas 592 
AP, Roxo E, Rocha AS, Suffys PN, Fonseca AA Jr, Silva MR, Barbosa Neto JD, 593 
Cerqueira VD, Araújo FR. 2014. Direct detection of Mycobacterium tuberculosis 594 
complex in bovine and bubaline tissues through nested-PCR.  Braz J Microbiol 45:633-595 
640. 596 
18. Courcoul A, Moyen J-L, Brugere L, Faye S, Henault S, Gares H, Boschiroli M-L. 597 
2014.   Estimation of sensitivity and specificity of bacteriology, histopathology and PCR 598 
for the confirmatory diagnosis of Bovine Tuberculosis using Latent Class Analysis.  PLoS 599 
ONE 9(3): e90334.  600 
19. Landis JR, Koch GG. 1977.  The measurement of observer agreement for categorical 601 
data.  Biometrics 33:159-174. 602 
20. Department of Agriculture, Environment and Rural Affairs. 2016.  Bovine 603 
Tuberculosis in Northern Ireland Annual Report 2015.  https://www.daera-604 
ni.gov.uk/publications/bovine-tuberculosis-northern-ireland-annual-reports. 605 
21. Baker C. 2015. Bovine TB Statistics: Great Britain. Briefing Paper Number 6081. 606 
http://researchbriefings.parliament.uk/ResearchBriefing/Summary/SN06081. 607 
22. Animal and Plant Health Agency. 2016. Bovine tuberculosis in England in 2015. 608 
Epidemiological analysis of the 2015 data and historical trends. 609 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/584527/tb-610 
epidemiology-england-2015.pdf. 611 
23 
 
23. Ministerio de Agricultura y Pesca Alimentación y Medio Ambiente, Spain. 2017.  612 
Programa Nacional de Erradicacion de Tuberculosis Bovina Presentado por España para 613 
el año 2017. http://www.mapama.gob.es/es/ganaderia/temas/sanidad-animal-higiene-614 
ganadera/pnetb_2017_3_tcm7-443753.pdf. 615 
24. Gortazar C, Vicente J, Boadella M, Ballesteros C, Galindo RC, Garrido J, Aranaz A, 616 
de la Fuente J. 2011. Progress in the control of Bovine Tuberculosis in Spanish wildlife.  617 
Vet Microbiol. 151:170-178. 618 
25. Hars J, Richomme C, Rivière J, Faure E, Boschiroli ML. 2012. Dix années de 619 
surveillance de la tuberculose bovine dans la faune sauvage française et perspectives. 620 
Bull Epidémiol. 52:1-5. 621 
26. Ferreira Neto JS, Bicca da Silveira G, Medeiros Rosa B, Picão Gonçalves VS, 622 
Hildebrand Grisi-Filho JH; Amaku M, Augusto Dias, R, Ferreira F, Heinemann MB, 623 
Oliveira Telles E, Pereira Lage A. 2016. Analysis of 15 years of the National Program for 624 
the Control and Eradication of Animal Brucellosis and Tuberculosis, Brazil. Semina: 625 
Ciências Agrárias 37(5,Suppl 2): 3385-3402.  626 
27. Rodriguez-Campos S, Smith NH, Boniotti MB, Aranaz A. 2014. Overview and 627 
phylogeny of Mycobacterium tuberculosis complex organisms: implications for 628 
diagnostics and legislation of bovine tuberculosis.  Res Vet Sci 97:S5-S19. 629 
28. Domogalla J, Prodinger WM, Blum H, Krebs S, Gellert S, Müller M,  Neuendorf E, 630 
Sedlmaier F, Büttnera M. 2013. Region of Difference 4 in Alpine Mycobacterium caprae 631 
Isolates Indicates Three Variants. J Clin Microbiol 51(5):1381–1388.  632 
29. Loeffler SH, de Lisle GW, Neill MA, Collins DM, Price-Carter M, Paterson B, Crews 633 
KB. 2014. The seal tuberculosis agent Mycobacterium pinnipedii, infects domestic cattle 634 
in New Zealand: Epidemiological factors and DNA strain typing. J. of Wildlife Dis:50, No. 635 
2. 180-187.  636 
30. Kremer K, Van Soolingen D, van Embden J, Hughes S, Inwald J, Hewinson G. 637 
1998. Mycobacterium microti: more widespread than previously thought.  J Clin Microbiol 638 
36:2793-2794. 639 
24 
 
31. Roring S, Hughes MS, Beck L-A, Skuce RA, Neill SD. 1998. Rapid diagnosis and 640 
strain differentiation of Mycobacterium bovis in radiometric culture by spoligotyping. Vet 641 
Microbiol 61:71-80. 642 
32. Skuce RA, Neill SD. 2001.  Molecular epidemiology of Mycobacterium bovis: exploiting 643 
molecular data.  Tuberculosis 81:169-175. 644 
33. Smith NH, Gordon SV, de la Rua-Domenech R, Clifton-Hadley RS, Hewinson RG. 645 
2006. Bottlenecks and broomsticks: the molecular evolution of Mycobacterium bovis. 646 
Nature Rev Microbiol 4:670-681.   647 
34. Zhang J, Abadia E, Refregier G, Tafaj S, Boschiroli ML, Guillard B, Andremont 648 
A, Ruimy R, Sola C. 2010. Mycobacterium tuberculosis complex CRISPR genotyping: 649 
improving efficiency, throughput and discriminative power of 'spoligotyping' with new 650 
spacers and a microbead-based hybridization assay. J Med Microbiol 59(3):285-294. 651 
35. Hauer A, De Cruz K, Cochard T, Godreuil S, Karoui C, Henault S, Bulach T, Bañuls 652 
A-L, Biet F, Boschiroli ML. 2015.  Genetic evolution of Mycobacterium bovis causing 653 
tuberculosis in livestock and wildlife in France since 1978. PLoS One 10(2): e0117103.   654 
36. Gortazar C, Vicente J, Samper S, Garrido JM, Fernandez-de-Mera IG, Garin P, 655 
Juste RA, Martin C, Acevedo P, de la Fuente M, Hofle U. 2005.  Molecular 656 
characterisation of Mycobacterium tuberculosis complex isolates from wild ungulates in 657 
south-central Spain.  Vet Res 36:43-52. 658 
37. Rodríguez S, Romero B, Bezos J, de Juan L, Alvarez J, Castellanos E, Moya N, 659 
Lozano F, González S, Sáez-Llorente JL, Mateos A., Domínguez L, Aranaz A. 2010.  660 
High spoligotype diversity within a Mycobacterium bovis population: clues to 661 
understanding the demography of the pathogen in Europe. Vet Microbiol 141:89-95.  662 
38. Said HM, Ismail N, Osman A, Velsman C, Hoosen AA.  2011.  Evaluation of TBc 663 
identification immunochromatographic assay for rapid identification of Mycobacterium 664 
tuberculosis complex in samples from broth cultures.  J Clin Microbiol 49:1939-1942.  665 
25 
 
39. Yu M-C, Chen H-Y, Wu M-H, Huang W-L, Kuo Y-M, Yu F-L, Jou R. 2011.  Evaluation 666 
of the rapid MGIT TBc Identification test for culture confirmation of Mycobacterium 667 
tuberculosis complex strain detection.  J Clin Microbiol 49:802-807. 668 
40. Martin A, Bombeeck D, Fissette K, de Rijk P, Hernández-Neuta I, Del Portillo P, 669 
Palomino JC. 2011.  Evaluation of the BD MGIT TBc Identification Test (TBc ID), a rapid 670 
chromatographic immunoassay for the detection of Mycobacterium tuberculosis complex 671 
from liquid culture.  J Microbiol Meth 84:255-257.  672 
41. Barouni AS, Alnajh ZB, Aboguttaia NB, Alamri WM. 2012. Evaluation of the BD 673 
MGITTM TBc identification test for rapid identification of Mycobacterium tuberculosis 674 
complex from positive BACTEC MGIT 960 cultures in a routine laboratory work.   Afr J 675 
Microbiol Res 6(5):1065-1068. 676 
42. Machado D, Ramos J, Couto I, Cadir N, Narciso I, Coelho E, Viegas S, Viveiros M. 677 
2014. Assessment of the BD MGIT TBc Identification test for the detection of 678 
Mycobacterium tuberculosis complex in a network of mycobacteriology laboratories.  679 
BioMed Res Int 2014:398108. 680 
 681 
26 
 
Table 1.  Multi-laboratory assessment of the specificity of the novel LFD by testing pure cultures of M. tuberculosis complex and non-682 
tuberculous Mycobacterium spp. grown in liquid culture media.  All liquid cultures tested signalled positive on the respective culture systems 683 
and, therefore, contained high numbers of mycobacteria (>106 CFU/ml) at time of testing. 684 
 685 
 686 Test Mycobacterium sp. 
QUB DORDOGNE  VISAVET/LRSA  SUN No. (%) LFD positive/ total 
no. cultures 
tested  
7H9/OADC BacT/ALERT® versaTREK® 
Myco 
MGITTM MGITTM 
  No. LFD positive / No. tested 
M. tuberculosis complex: 
M. bovis 6/6* 4/4 8/8 - 23/25 41/43 (95.3) 
M. caprae - 1/1 1/1 - - 2/2 (100) 
M. bovis BCG 1/1 - - - - 1/1 (100) 
M. pinnipedii - - - 1/1 - 1/1 (100) 
M. africanum - 0/1 0/1 - - 0/2 (0) 
M. microti - 0/1 0/1 - - 0/2 (0) 
M. tuberculosis 0/1 0/1 0/1 - 0/41 0/44 (0) 
Non-tuberculous mycobacteria: 
M. abscessus - - - - 0/1 0/1 (0) 
M. asiaticum - - - - 0/1 0/1 (0) 
M. avium subsp. avium 0/1 0/1 0/1 0/1 - 0/4 (0) 
M. avium subsp. paratuberculosis 0/10 0/2 0/2 - - 0/14 (0) 
M. chelonae - - - - 0/1 0/1 (0) 
M. columbiense - - - 0/1 - 0/1 (0) 
M. diernhoferi - - - - 0/1 0/1 (0) 
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 687 
 688 
 689 
 690 
 691 
 692 
 693 
 694 
 695 
 696 
 697 
 698 
 699 
 700 
 701 
 702 
 703 
 704 
-, not tested 705 
* M. bovis spoligotypes tested – SB0140, SB0129, SB0273, SB0142, SB0263 and SB0145, according to Mbovis.org database.  706 
** very weak T-line observed, but slightly increasing blocking buffer concentration prevented this false positive result.707 
M. elephantis - - - - 0/1 0/1 (0) 
M. fortuitum 0/1 - - 0/1 0/1 0/3 (0) 
M. gordonae 0/1 - - - - 0/1 (0) 
M. hassiacum - - - - 0/1 0/1 (0) 
M. hiberniae 0/1 - - - - 0/1 (0) 
M. interjectum - - - - 0/1 0/1 (0) 
M. intracellulare 0/1 - - 0/1 - 0/2 (0) 
M. kansasii 0/1 1/1 (v. weak)** 0/1 0/1 - 1/4 (25) 
M. lentiflavum - - - - 0/1 0/1 (0) 
M. marinum 0/1 - - 0/1 - 0/2 (0) 
M. moriokaense - - - - 0/1 0/1 (0) 
M. nonchromogenicum - 0/1 0/1 - 0/2 (0) 
M. paraffinicum - - - - 0/1 0/1 (0) 
M. parascrofulaceum - - - - 0/1 0/1 (0) 
M. peregrinum - - - 0/1 - 0/1 (0) 
M. porcinum - - - - 0/1 0/1 (0) 
M. scrofulaceum 0/1 - - - - 0/1 (0) 
M. simiae - - - - 0/1 0/1 (0) 
M. smegmatis 0/1 - - 0/1 - 0/2 (0) 
M. terrae 0/1 - - - - 0/1 (0) 
M. vulneris - - - - 0/1 0/1 (0) 
M. xenopi 0/1 - - - - 0/1 (0) 
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Table 2.  Multi-laboratory assessment of the specificity of the novel LFD involving pure 708 
cultures of Mycobacterium tuberculosis complex and non-tuberculous Mycobacterium spp. 709 
grown on different solid culture media (Coletsos, Lowenstein-Jensen (LJ) or Stonebrink).  710 
Data represent number of solid cultures LFD positive of the total number of solid cultures 711 
tested in each case.  712 
 713 
-, not tested  714 
*Dordogne laboratory reported Control (C) line absent, with and/or without positive Test (T) 715 
line, so LFD result was ‘Invalid’. 716 
** M. caprae spoligotypes tested by VISAVET/LRSA: SB0416, SB0418, SB2205, SB2281, 717 
according to Mbovis.org database. 718 
 719 
  720 
Test Mycobacterium sp. 
DORDOGNE VISAVET/LRSA EMBRAPA No. (%) LFD 
positive/ 
total no. 
cultures 
tested 
Coletsos
medium 
Lowenstein-
Jensen (LJ) 
medium 
LJ/pyruvate 
medium 
Stonebrink 
medium 
M. tuberculosis 
complex: 
   
M. bovis 3/11* 5/9* - 52/60 
60/80 
(75.0) 
M. caprae 1/1 
- 
5/10** 
- 6/11 
(54.5) 
M. bovis BCG 1/2* - - - 1/2 (50) 
M. pinnipedii 1/1 - - - 1/1 (100) 
M. africanum 0/1 - - - 0/1 (0) 
M. microti - - 0/1 - 0/1 (0) 
M. tuberculosis 0/1 - - - 0/1 (0) 
    
Non-tuberculous mycobacteria:    
M. avium subsp. avium 0/1 - - 0/1 0/2 (0) 
M. chelonae - - - 0/1 0/1 (0) 
M. fortuitum - - - 0/1 0/1 (0) 
M. kansasii 0/1 - - - 0/1 (0) 
M. nonchromogenicum 
 
0/1 
 
- - 
 
- 0/1 (0) 
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Table 3.  Performance of novel LFD test applied to liquid mycobacterial cultures (BD MGIT or BioMerieux BacT/Alert) of specimens from a 
range of animal species in comparison with usual confirmatory test(s) applied in multiple veterinary diagnostic laboratories. 
Laboratory (Country) Liquid culture system 
employed 
(No. cultures tested)  
Animal 
species 
represented 
Confirmatory test(s) 
routinely applied to 
liquid cultures 
No. cultures 
confirmed M. 
bovis or MTBC 
positive3 
No. cultures 
LFD positive 
% of confirmed 
cultures testing 
LFD positive 
AFBI (N. Ireland, UK) MGIT (240 categorised1) 
MGIT (105 real-time2) 
 
Cattle, 
badgers 
Ziehl-Neelsen stain + 
spoligotyping 
 
132 
38 
141 
40 
1004 
1004 
APHA (UK) MGIT (190 categorised1) Cattle, 
badgers 
Ziehl-Neelsen stain + 
spoligotyping 
 
89 88 98.9 
DORDOGNE 
(France) 
BacT/Alert (52) Cattle, 
badgers 
 
qPCR  
 
52 22 42.3 
VISAVET/LRSA 
(Spain) 
MGIT (78) Cattle, goat, 
wild boar, 
deer 
qPCR  
 
Spoligotyping5 
78 
 
50 
39  
 
38 
 
50.0 
 
76.0 
 
1 Cultures were categorised before LFD testing, as described in Materials and Methods section, and were held in an incubator until all cultures 
in each category became available before LFD testing commenced.  
2 Cultures were tested as soon as possible after they indicated growth positive on the MGIT 960 instrument, with minimal additional incubation 
time before LFD testing commenced.  
3 Confirmation as M. bovis when spoligotyping applied, but otherwise confirmation to MTBC level by qPCR.  
4 The LFD detected 9 and 3 extra M. bovis positive MGIT cultures than spoligotyping for the categorised and real-time cultures, respectively. 
5 Spoligotyping identified all the strains as MTBC but only 50 were identified as M. bovis or M. caprae with the spoligotyping profile.  A 
breakdown of the spoligotyping results by animal species is provided in Table 4.  
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Table 4.  Breakdown of spoligotyping results for 78 qPCR positive MGIT cultures tested at 
VISAVET/LRSA and for the 39 MGIT cultures that tested LFD positive.  
 
Origin of  specimen  
M. bovis  
spoligotype present 
M. caprae 
spoligotype present 
Unable to assign 
spoligotype4 
No.  No. LFD + No. No. LFD + No. No. LFD + 
Cattle (n=40) 25 171 1 1 14 1 
Goats (n=18) 11 102 7 43 0 0 
Wild boar (n=17) 4 4 0 0 13 0 
Deer (n=3) 2 2 0 0 1 0 
1 LFD did not detect eight confirmed M. bovis positive MGIT cultures containing five different 
spoligotypes (3 x SB0121, 2 x SB0295, SB0134, SB0339 and SB0152). 
2 LFD did not detect one confirmed M. bovis positive MGIT culture containing spoligotype 
SB0121. 
3 LFD did not detect three confirmed M. caprae positive MGIT cultures containing three 
different spoligotypes (SB0415, SB0416 and SB0157).  
4 Cultures tested MTBC positive by qPCR and spoligotyping, but neither Mycobacterium 
species nor a specific spoligotype could be assigned.   
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Table 5.  Performance of novel LFD test applied to colonies from solid cultures of confirmed M. bovis cattle isolates in two veterinary diagnostic 1 
laboratories.  2 
Laboratory (Country) Solid culture medium employed 
(No. of cultures tested) 
LFD result1 % of cultures 
confirmed as M. bovis 
by LFD 
Positive Negative Invalid 
  No. of cultures  
DORDOGNE (France) Coletsos (9) 
Lowenstein-Jensen (9) 
1 
5 
0 
0 
8 
4 
 
11.1 
55.6 
EMBRAPA (Brazil) Stonebrink:  
Fresh sub-cultures (37) 
Old cultures (23) 
 
33 
19 
 
 
4 
4 
 
0 
0 
 
89.2 
82.6 
1 LFD result is ‘positive’ when both C-line and T-line are visible, ‘negative’ if only C-line is visible and ‘Invalid’ if no C-line was present along with 3 
a positive T-line.   4 
 5 
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Table 6.  Comparison of the ability of the novel LFD and the commercially available BD 6 
MGITTM TBc ID test to confirm the presence of Mycobacterium bovis in 190 MGIT cultures of 7 
bovine lymph tissue tested by APHA. Data were analysed by Fisher’s exact test and Kappa 8 
interrater test.   9 
LFD test result MGIT 
culture +1 
MGIT 
culture - 
Kappa 
statistic 
(95% CI) 
Detection 
sensitivity 
(95% CI) 
Detection 
specificity  
(95% CI) 
Novel LFD + 88 0 0.979 
(0.950-1.000)
0.978 
(0.922-0.997) 
1.000 
(0.963-1.000) Novel LFD - 2 100 
MGIT TBc ID test + 89 1 0.979 
(0.950-1.000)
0.989 
(0.940-0.999) 
0.990 
(0.946-0.999) MGIT TBc ID test - 1 99 
1 Only recorded as ‘Culture +’ when presence of M. bovis was confirmed by spoligotyping.  10 
 11 
 12 
 13 
 14 
 15 
 16 
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Figure legends 17 
Figure 1.  Comparison of the numbers of liquid cultures at (A) VISAVET/LRSA (MGIT 18 
cultures) and (B) DORDOGNE (BacT/ALERT cultures) testing positive by the novel LFD 19 
(light bars) and by MTBC-specific qPCR (and spoligotyping in case of VISAVET/LRSA data) 20 
(dark bars).   21 
Figure 2. Comparison of the numbers of confirmed M. bovis solid cultures tested at 22 
EMBRAPA testing positive by novel LFD (light bars) and two qPCR methods (dark bars): (A) 23 
TbD1 qPCR and (B) Rv2807 qPCR.  24 
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